Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY, FIMM | Sorafenib |
CTRPv2 | sorafenib |
PharmacoGx | Sorafenib |
Database | Identifier |
---|---|
Smiles: | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F |
Inchikey: | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
Pubchem: | 216239 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GALNT1 | FIMM | pan-cancer | AAC | 0.47 | 0.01 |
mRNA | NEK1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | MFSD1 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | MRPL32 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | HSPB9 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
mRNA | TRAF5 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | PPP6R1 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.01 |
mRNA | CCAR2 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | FERD3L | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | CA2 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |